One additional mutation at exon A amplifies thermolability of androgen receptor in a case with complete androgen insensitivity syndrome

Gynecological Endocrinology

Volumn 12, Issue 2, 1998, Pages 75-82

  Tanaka, H ^a   Komori, S ^a   Sakata, K ^a   Shima, H ^a   Koyama, K ^a  

^a HYOGO COLLEGE OF MEDICINE   (Japan)

Author keywords

Androgen receptor; Complete androgen insensitivity syndrome; Point mutation; Thermolability

Indexed keywords

ANDROGEN RECEPTOR;

AMINO ACID SUBSTITUTION; AMINO TERMINAL SEQUENCE; ANDROGEN INSENSITIVITY SYNDROME; ANIMAL CELL; ARTICLE; EXON; HUMAN; NONHUMAN; PRIORITY JOURNAL; THERMOSTABILITY;

EID: 0031961510     PISSN: 09513590     EISSN: None     Source Type: Journal    
DOI: 10.3109/09513599809024954     Document Type: Article

References (33)

1. Imperato-McGinley J, Peterson RE. Male pseudohermaphroditism: the complexities of male phenotypic development. Am J Med 1976; 61:251-72
2. McPhaul MJ, Marcelli M, Zoppi S, et al. Genetic basis of endocrine disease. 4. The spectrum of mutations in the androgen receptor gene that cause androgen resistance. J Clin Endocrinol Metab 1993; 76:17-23
3. Lobaccaro J, Lumbroso S, Poujol N, et al. Molecular genetics of androgen insensitivity syndromes. Cell Mol Biol 1994;40:301-8
4. Evans RM. The steroid and thyroid hormone receptor superfamily. Science 1988;240:889-95
5. Liao S, Kokontis J, Sai T, et al. Androgen receptors: structures, mutations, antibodies and cellular dynamics. J Steroid Biochem 1989;34:41-51
6. Chang C, Kokontis J, Liao S. Structural analysis of complementary DNA and amino acid sequences of human and rat androgen receptors. Proc Natl Acad Sci USA 1988;85:7211-15
7. Trapman J, Klaassen P, Kuiper GGJM, et al. Cloning, structure and expression of cDNA encoding the human androgen receptor. Biochem Biophys Res Commun 1988;153:241-8
8. Kuiper GGJM, Faber PW, van Rooij HCJ, et al. Structural organization of the human androgen receptor gene. J Mol Endocrinol 1989;2:R1-R4
9. Sultan C, Lumbroso S, Poujol N, et al. Mutations of androgen receptor gene in androgen insensitivity syndromes. J Steroid Biochem Mol Biol 1993;46: 519-30
10. Kasumi H, Komori S, Yamasaki N, et al. Single nucleotide substitution of the androgen receptor gene in a case with receptor-position androgen insensitivity syndrome. Acta Endocrinol 1993; 128:355-60
11. La Spada AR, Wilson EM, Lubahn DB, et al. Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy. Nature 1991; 352:77-9
12. Sobue G, Doyu M, Morishima T, et al. Aberrant androgen action and increased size of tandem CAG repeat in androgen receptor gene in X-linked recessive bulbospinal neuropathy. J Neurol Sci 1994; 121:167-71
13. Lubahn DB, Brown TR, Simental JA, et al. Sequence of the intron/exon junctions of the coding region of the human androgen receptor gene and identification of a point mutation in a family with complete androgen insensitivity. Proc Natl Acad Sci USA 1989;86:9534-8
14. Sanger F, Nichklen S, Coulson AR. DNA sequencing with chain terminating inhibitors. Proc Natl Acad Sci USA 1977;74:5463-7
15. Rundlett SE, Wu X-P, Miesfeld RL. Functional characterization of the androgen receptor confirm that the molecular basis of androgen action is transcriptional regulation. Mol Endocrinol 1990; 4:708-14
16. Terakawa T, Shima H, Yabumoto H, et al. Androgen receptor levels in patients with isolated hypospadias. Acta Endocrinol (Copenh) 1990;123:24-9
17. McPhaul MJ, Marcelli M, Zoppi S, et al. Mutations in the ligand-binding domain of the androgen receptor gene cluster in two regions of the gene. J Clin Invest 1992;90:2097-101
18. Adeyemo O, Kallio PJ, Palvimo JJ, et al. A single-base substitution in exon 6 of the androgen receptor gene causing complete androgen insensitivity: the mutated receptor fails to transactivate but binds to DNA in vitro. Hum Mol Genet 1993;2:1809-12
19. Beitel LK, Prior L, Vasiliou DM, et al. Complete androgen insensitivity due to mutations in the probable α-helical segments of DNA-binding domain in the human androgen receptor. Hum Mol Genet 1994;3:21-7
20. Wamar N, Yu C, Pahe N, et al. Substitution of Cys-560 by Phe, Trp, Tyr, and Ser in the first zinc finger of human androgen receptor affects hormonal sensitivity and transcriptional activation. J Biol Chem 1994;269:29016-23
21. Bourguet W, Ruff M, Chambon P, et al. Crystal structure of the ligand-binding domain of the human nuclear receptor RXR-α. Nature 1995; 375:377-82
22. Veldscholte J, Ris-Stalpers C, Kuiper GGJM, et al. A mutation in the ligand binding domain of the androgen receptor of human LNCaP cells affects steroid binding characteristics and response to antiandrogens. Biochem Biophys Res Commun 1990;173: 534-40
23. Prior L, Bordet S, Trifiro MA, et al. Replacement of arginine 773 by cysteine or histidine in the human androgen receptor causes complete androgen insensitivity with different receptor phenotypes. Am J Hum Genet 1992;51:143-55
24. de Bellis A, Quigley CA, Marschke KB, et al. Characterization of mutant androgen receptors causing partial androgen insensitivity syndrome. J Clin Endocrinol Metab 1994;78:513-22
25. Beitel LK, Kazemi-Esfarjani P, Kaufman M, et al. Substitution of arginine-839 by cysteine or histidine in the androgen receptor cause different receptor phenotypes in cultured cells and coordinate degrees of clinical androgen resistance. J Clin Invest 1994;94:546-54
26. Lumbroso S, Lobaccaro JM, Belon C, et al. Molecular prenatal exclusion of familial partial androgen insensitivity (Reifenstein syndrome). Eur J Endocrinol 1994;130:327-32
27. 840Arg-His) in the hormone-binding domain of the androgen receptor leads to incomplete androgen insensitivity syndrome associated with a thermolabile androgen receptor. Eur J Endocrinol 1994;130:569-74
28. Onate SA, Tsai SY, Tsai M-J, et al. Sequence and characterization of a coactivator for the steroid hormone receptor superfamily. Science 1995; 270:1354-7
29. Simental JA, Sar M, Lane MV, et al. Transcriptional activation and nuclear targeting signal of the human androgen receptor. J Biol Chem 1991;266:510-18
30. McPhaul MJ, Marcelli M, Tilley WD, et al. Molecular basis of androgen resistance in a family with a qualitative abnormality of the androgen receptor and responsive to high-dose androgen therapy. J Clin Invest 1991;87:1413-21
31. MacLean HE, Warne GL, Zajac JD. Defects of androgen receptor: from sex reversal to motor neurone disease. Mol Cell Endocrinol 1995;112: 133-41
32. Rubinsztein DC, Leggo J, Coetzee GA, et al. Sequence variation and size ranges of CAG repeats in the Machado-Joseph disease, spinocerebellar ataxia type 1 and androgen receptor. Hum Mol Genet 1995;4:1585-90
33. Komori S, Tanaka H, Sakata K, et al. Shortage of glutamine (CAG) homopolymeric repeats suppresses the expression of the androgen receptor in familial cases with complete androgen insensitivity syndrome. Gynecol Endocrinol 1998;12:1-8